Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Jul 27;9:201. doi: 10.1186/s13287-018-0947-5

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s). 2018

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 12 — Application of hiPSC technology in cardiovascular medicine. Fibroblasts can be obtained from skin biopsies and derived into iPSCs in vitro as previously discussed. iPSC differentiation into CMs allows the study of the cellular and mechanical aspects of a variety of genetic diseases. In vitro drug screening for reversion of the particular affliction can be tested on such “diseased” CMs. When derived from healthy donors, iPSCs and CMs can be used to test the cardiac toxicity of drugs. The use of “healthy” iPSC-CMs for cellular therapy is also considered as a potential application of iPSC technology in regenerative medicine. CM cardiomyocyte, iPSC induced pluripotent stem cell